CEBPA and acute myeloid leukemia: As favorable prognostic markers, a mutation of the NPM1 gene that generates cytoplasmic NPM1 (NPM1c) is found in approximately 5–8% of pediatric AML and 20–30% in adult AML, and biallelic CEBPA mutations in approximately 5% of both pediatric and adult AML [35,36].